Scholars Central

EditorialPublished 30 Nov 2024

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) During Surgery

Authors: Theophile Dubois

Cancer Surgery

Volume 9 · Issue 6 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has emerged as an effective therapeutic approach for managing peritoneal carcinomatosis, particularly in patients with colorectal, ovarian, gastric, and mesothelioma cancers. HIPEC is performed during surgery, following cytoreductive surgery (CRS) to remove visible tumors. The procedure involves delivering heated chemotherapy directly into the peritoneal cavity, which enhances the cytotoxic effects of the drugs and allows for better penetration into the cancerous tissues. This article explores the principles, indications, outcomes, and challenges associated with HIPEC during cancer surgery. It also highlights recent advancements in HIPEC technology, including improved drug delivery systems and techniques aimed at maximizing patient benefit. Ultimately, the goal of HIPEC is to increase survival rates while minimizing the risk of recurrence in patients with advanced peritoneal cancers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Surgery.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Surgery
  • SubjectOncology & Cancer
  • SubjectSurgery
  • BylineArticles whose byline prints “Theophile Dubois”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels